Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.
about
Meta-analysis reveals significant association of 3'-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations.Pathways to precision medicine in smoking cessation treatments.Pharmacogenetic Optimization of Smoking Cessation Treatment.Integrating genetics and social science: genetic risk scoresBiomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.Leveraging genomic data in smoking cessation trials in the era of Precision Medicine: Why and how.Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation.The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
P2860
Q30279060-FD5BDE42-50BE-4FF9-AF27-65C14EA6B91FQ34527740-DFFB871B-EFEE-4D41-8838-DED42AE91A1AQ34542169-6B42387D-D746-4A13-8509-D58A54F4609EQ34762110-093C6070-A071-4F03-A689-CB801D79B903Q35751986-57B86BC2-98EB-4A6A-A62C-B1CABA682C58Q35956179-482D926E-C8BA-4293-9BCF-CF477DDA1446Q36370325-F4DDC7B5-92C6-47DB-90A1-0E9B51D3839FQ36847884-5B0824F5-E228-485E-A698-D2C7CCD13B2CQ47852468-4E862CEB-3366-408D-A8D2-350661C53DC0Q48015634-C2745913-45C3-419E-9199-D7BE3AC986D2
P2860
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@en
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@nl
type
label
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@en
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@nl
prefLabel
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@en
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@nl
P2093
P2860
P50
P356
P1433
P1476
Influence of a dopamine pathwa ...... clinical trials of bupropion.
@en
P2093
Adam M Leventhal
David R Strong
David V Conti
Gary E Swan
John E McGeary
Molly A Lancaster
Neal L Benowitz
Rachel F Tyndale
Richard A Brown
P2860
P304
P356
10.1111/ADD.12325
P407
P577
2013-09-18T00:00:00Z